Skip to content
value.today

Sequenom Inc.

Total raised
$53 M
2 rounds on record
Latest round
$52 M
May 2010
First round on record
Dec 2009
Today
Private
No later event on record

Funding rounds

2 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Sequenom Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2015$85 MIssued in a merger or acquisition$50 to $250 million

Sequenom Inc.: Private sale, Jun 2015

Investors in this round

10 investors had bought by the notice of Jun 19, 2015: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$85 M of $85 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,487,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carolyn F. Beaver · Executive Officer
  • Daniel S. Grosu · Executive Officer
  • Dirk van den Boom · Executive Officer, Director
  • Jeff M. Linton · Executive Officer
  • Robin S. Weiner · Executive Officer
  • William S. Welch · Executive Officer, Director
  • Charles M. Slacik · Director
  • David M. Pendarvis · Director
  • John A. Fazio · Director
  • Kenneth F. Buechler · Director
  • Myla S. Lai-Goldman · Director
  • Richard A. Lerner · Director
  • Ronald M. Lindsay · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Lazard Feres & Co. (CRD 2528) · San Francisco, CaliforniaSold in CA, CT, IL, NJ, NV, NY

Remarks in the notice

  • On the amounts: “Represents the aggregate principal amount of 5.00% Convertible Exchange Senior Notes due 2018, which were exchanged for existing notes in the same amount.”
  • On a merger: “Exchange of $85,000,000 in original principal amount of 5.00% Convertible Senior Notes due 2017 for $85,000,000 in original principal amount of 5.00% Convertible Exchange Senior Notes due 2018”

Signed by Jeff Linton, Vice President, General Counsel and Secretary. Source: SEC Form D, newest notice filed Jun 19, 2015. Read the notice at the SEC.

debt, optionsSEC
May 2010$52 MNo. 2$50 to $250 million

Sequenom Inc.: Raise no. 2, May 2010

Investors in this round

18 investors had bought by the notice of May 24, 2010: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$52 M of $52 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
$3,200,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander T. Monko · Executive Officer
  • Alisa T. Judge · Executive Officer
  • Allen T. Bombard · Executive Officer
  • Charles R. Cantor · Executive Officer, Director
  • Clarke T. Neumann · Executive Officer
  • Harry F. Hixson · Executive Officer, Director
  • Larry T. Myres · Executive Officer
  • Paul W. Maier · Executive Officer
  • Ronald M. Lindsay · Executive Officer, Director
  • Shawn T. Marcell · Executive Officer
  • David M. Pendarvis · Director
  • Ernst-Gunter F. Afting · Director
  • John A. Fazio · Director
  • Kathleen W. Wiltsey · Director
  • Kenneth F. Buechler · Director
  • Richard A. Lerner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Lazard Capital Markets LLC (CRD 134736) · broker-dealer Lazard Capital Markets LLC (CRD 134736) · New York, New YorkSold in CA, NY
  • Jefferies & Company, Inc. (CRD 2347) · broker-dealer Jefferies & Company, Inc. (CRD 2347) · New York, New YorkSold in CA, NY

Signed by Clarke W. Neumann, Vice President, General Counsel and Secretary. Source: SEC Form D, newest notice filed May 24, 2010. Read the notice at the SEC.

equitySEC
Dec 2009$2 MNo. 1Under $2 million

Sequenom Inc.: Raise no. 1, Dec 2009

Investors in this round

27 investors had bought by the notice of Dec 29, 2009: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander T. Monko · Executive Officer
  • Alisa T. Judge · Executive Officer
  • Allen T. Bombard · Executive Officer
  • Charles R. Cantor · Executive Officer, Director
  • Clarke T. Neumann · Executive Officer
  • Gary T. Riordan · Executive Officer
  • Harry F. Hixson · Executive Officer, Director · Interim CEO
  • Larry T. Myres · Executive Officer
  • Paul W. Maier · Executive Officer · Interim Chief Financial Officer
  • Ronald M. Lindsay · Executive Officer, Director · Interim Senior Vice President, Research & Development
  • Shawn T. Marcell · Executive Officer
  • David M. Pendarvis · Director
  • Ernst-Gunter F. Afting · Director
  • John A. Fazio · Director
  • Kathleen W. Wiltsey · Director
  • Kenneth F. Buechler · Director
  • Richard A. Lerner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Rprsnts the value of an agg of 367,547 shs issued 12/21 & 12/23,based on the clsng price of Issuer's Comm Stck on such dates.These shs were issued in consid. of the release of certain claims;no cash was received by the Issuer for the issuance of the shs”

Signed by Clarke W. Neumann, Vice President, General Counsel and Secretary. Source: SEC Form D, newest notice filed Dec 29, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sequenom Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2015).

    SEC Form D · Jun 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2015

That is all the official record says: Sequenom Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: the address on record now leads to another company's site.

Investors#

No investor of Sequenom Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 27 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sequenom Inc.
NameRoleNamed in
Carolyn F. BeaverExecutive officerJun 2015
Daniel S. GrosuExecutive officerJun 2015
Dirk van den BoomExecutive officerJun 2015
Jeff M. LintonExecutive officerJun 2015
Robin S. WeinerExecutive officerJun 2015
William S. WelchExecutive officerJun 2015
Alexander T. MonkoExecutive officerMay 2010
Alisa T. JudgeExecutive officerMay 2010
Allen T. BombardExecutive officerMay 2010
Charles R. CantorExecutive officerMay 2010
Clarke T. NeumannExecutive officerMay 2010
Harry F. HixsonExecutive officerMay 2010
Larry T. MyresExecutive officerMay 2010
Paul W. MaierExecutive officerMay 2010
Ronald M. LindsayExecutive officerMay 2010
Shawn T. MarcellExecutive officerMay 2010
Gary T. RiordanExecutive officerDec 2009
Charles M. SlacikDirectorJun 2015
David M. PendarvisDirectorJun 2015
Dirk van den BoomDirectorJun 2015
John A. FazioDirectorJun 2015
Kenneth F. BuechlerDirectorJun 2015
Myla S. Lai-GoldmanDirectorJun 2015
Richard A. LernerDirectorJun 2015
Ronald M. LindsayDirectorJun 2015
William S. WelchDirectorJun 2015
Charles R. CantorDirectorMay 2010
Ernst-Gunter F. AftingDirectorMay 2010
Harry F. HixsonDirectorMay 2010
Kathleen W. WiltseyDirectorMay 2010

About

American life sciences company.